Pular para o conteúdo
Merck
Todas as fotos(1)

Key Documents

194824

Sigma-Aldrich

Borane dimethyl sulfide complex solution

2.0 M in toluene

Sinônimo(s):

BMS, Trihydro[thiobis[methane]]boron

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Fórmula linear:
(CH3)2S · BH3
Número CAS:
Peso molecular:
75.97
Beilstein:
3663489
Número MDL:
Código UNSPSC:
12352112
ID de substância PubChem:

adequação da reação

reagent type: reductant

concentração

2.0 M in toluene

densidade

0.856 g/mL at 25 °C

cadeia de caracteres SMILES

B.CSC

InChI

1S/C2H6S.BH3/c1-3-2;/h1-2H3;1H3

chave InChI

RMHDLBZYPISZOI-UHFFFAOYSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Aplicação

Reactant used as a regioselective reducing agent

Reactant involved in:
  • Hydroboration / oxidation
Synthesis of cage compounds

Palavra indicadora

Danger

Classificações de perigo

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Aquatic Chronic 3 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 2 - STOT SE 3 - Water-react 1

Órgãos-alvo

Central nervous system

Perigos de suplementos

Código de classe de armazenamento

4.3 - Hazardous materials which set free flammable gases upon contact with water

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

44.6 °F - closed cup

Ponto de fulgor (°C)

7 °C - closed cup

Equipamento de proteção individual

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter


Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Kathleen C Rollet-Kurhajec et al.
PloS one, 10(6), e0129868-e0129868 (2015-06-20)
In Hepatitis C virus (HCV) mono-infection, male sex is associated with faster liver fibrosis progression but the effects of sex have not been well studied in HIV-HCV co-infected patients. We examined the influence of sex on progression to significant liver
A Burchert et al.
Leukemia, 29(6), 1331-1335 (2015-02-26)
A minority of chronic myeloid leukemia (CML) patients is capable of successfully discontinuing imatinib. Treatment modalities to increase this proportion are currently unknown. Here, we assessed the role of interferon alpha 2a (IFN) on therapy discontinuation in a previously reported
Andrew J Saykin et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 11(7), 792-814 (2015-07-22)
Genetic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) have been crucial in advancing the understanding of Alzheimer's disease (AD) pathophysiology. Here, we provide an update on sample collection, scientific progress and opportunities, conceptual issues, and future plans. Lymphoblastoid cell
Saskia Ditisheim et al.
Inflammatory bowel diseases, 21(11), 2598-2604 (2015-08-06)
Inflammatory bowel diseases (IBD) are systemic conditions that commonly display extraintestinal manifestations. Inflammatory articular disease (IAD: axial or peripheral) is the most common extraintestinal manifestation. The aim of this study was to evaluate the prevalence and the clinical characteristics associated
Veena K Ranganath et al.
Arthritis care & research, 67(7), 929-939 (2015-01-13)
To evaluate the effect of sustained American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) Boolean remission on residual joint inflammation assessed by magnetic resonance imaging (MRI) and to secondarily evaluate other clinical definitions of remission, within an early seropositive

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica